Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
Clinical trial NCT05328024 · RECRUITING
Trial details
- NCT number
- NCT05328024
- Sponsor
- Centre Paul Strauss
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-25
- Primary completion
- 2029-08-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.